Combination MET inhibition and Topoisomerase I inhibition block cell growth of Small Cell Lung Cancer

Small cell lung cancer (SCLC) is a devastating disease, and current therapies have not greatly improved the 5-year survival rates. Topoisomerase (Top) inhibition is a treatment modality for SCLC; however, the response is short lived. Consequently, our research has focused on improving SCLC therapeut...

詳細記述

保存先:
書誌詳細
出版年:Mol Cancer Ther
主要な著者: Rolle, Cleo E., Kanteti, Rajani, Surati, Mosmi, Nandi, Suvobroto, Dhanasingh, Immanuel, Yala, Soheil, Tretiakova, Maria, Arif, Qudsia, Hembrough, Todd, Brand, Toni M., Wheeler, Deric L., Husain, Aliya N., Vokes, Everett E., Bharti, Ajit, Salgia, Ravi
フォーマット: Artigo
言語:Inglês
出版事項: 2013
主題:
Article
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC4286701/
https://ncbi.nlm.nih.gov/pubmed/24327519
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1535-7163.MCT-13-0109
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料